BlackRock Institutional Trust’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $10.7M | Buy |
516,855
+12,334
| +2% | +$255K | ﹤0.01% | 2359 |
|
|
2016
Q3 | $8.18M | Sell |
504,521
-10,418
| -2% | -$169K | ﹤0.01% | 2452 |
|
|
2016
Q2 | $7M | Buy |
514,939
+22,532
| +5% | +$306K | ﹤0.01% | 2501 |
|
|
2016
Q1 | $8.6M | Buy |
492,407
+53,008
| +12% | +$925K | ﹤0.01% | 2356 |
|
|
2015
Q4 | $15M | Buy |
439,399
+147,599
| +51% | +$5.04M | ﹤0.01% | 2056 |
|
|
2015
Q3 | $8.68M | Buy |
291,800
+88,293
| +43% | +$2.63M | ﹤0.01% | 2385 |
|
|
2015
Q2 | $6.51M | Buy |
203,507
+104,776
| +106% | +$3.35M | ﹤0.01% | 2649 |
|
|
2015
Q1 | $2.05M | Buy |
98,731
+4,109
| +4% | +$85.2K | ﹤0.01% | 3096 |
|
|
2014
Q4 | $1.6M | Buy |
94,622
+484
| +0.5% | +$8.2K | ﹤0.01% | 3197 |
|
|
2014
Q3 | $1.82M | Sell |
94,138
-26,562
| -22% | -$514K | ﹤0.01% | 3110 |
|
|
2014
Q2 | $4.1M | Sell |
120,700
-30,893
| -20% | -$1.05M | ﹤0.01% | 2868 |
|
|
2014
Q1 | $4.78M | Buy |
+151,593
| New | +$4.78M | ﹤0.01% | 2804 |
|